1. Home
  2. SNY vs LOW Comparison

SNY vs LOW Comparison

Compare SNY & LOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNY
  • LOW
  • Stock Information
  • Founded
  • SNY 1994
  • LOW 1946
  • Country
  • SNY France
  • LOW United States
  • Employees
  • SNY N/A
  • LOW N/A
  • Industry
  • SNY Biotechnology: Pharmaceutical Preparations
  • LOW RETAIL: Building Materials
  • Sector
  • SNY Health Care
  • LOW Consumer Discretionary
  • Exchange
  • SNY Nasdaq
  • LOW Nasdaq
  • Market Cap
  • SNY 142.6B
  • LOW 148.9B
  • IPO Year
  • SNY N/A
  • LOW N/A
  • Fundamental
  • Price
  • SNY $54.86
  • LOW $281.31
  • Analyst Decision
  • SNY Buy
  • LOW Buy
  • Analyst Count
  • SNY 2
  • LOW 24
  • Target Price
  • SNY $57.50
  • LOW $267.38
  • AVG Volume (30 Days)
  • SNY 1.7M
  • LOW 2.2M
  • Earning Date
  • SNY 10-25-2024
  • LOW 11-19-2024
  • Dividend Yield
  • SNY 3.73%
  • LOW 1.64%
  • EPS Growth
  • SNY N/A
  • LOW 20.25
  • EPS
  • SNY 3.60
  • LOW 12.06
  • Revenue
  • SNY $50,444,658,733.00
  • LOW $84,023,000,000.00
  • Revenue This Year
  • SNY $4.07
  • LOW N/A
  • Revenue Next Year
  • SNY $6.88
  • LOW $1.98
  • P/E Ratio
  • SNY $30.36
  • LOW $23.33
  • Revenue Growth
  • SNY 2.25
  • LOW N/A
  • 52 Week Low
  • SNY $42.63
  • LOW $181.85
  • 52 Week High
  • SNY $58.97
  • LOW $287.01
  • Technical
  • Relative Strength Index (RSI)
  • SNY 41.80
  • LOW 70.27
  • Support Level
  • SNY $53.84
  • LOW $280.81
  • Resistance Level
  • SNY $55.12
  • LOW $287.01
  • Average True Range (ATR)
  • SNY 0.75
  • LOW 4.64
  • MACD
  • SNY -0.21
  • LOW 0.44
  • Stochastic Oscillator
  • SNY 24.70
  • LOW 76.10

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 20% of total sales, but profits are shared with Regeneron. About 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

About LOW Lowe's Companies Inc.

Lowe's is the second-largest home improvement retailer in the world, operating more than 1,700 stores in the United States, after the 2023 divestiture of its Canadian locations (RONA, Lowe's Canada, Réno-Dépôt, and Dick's Lumber). The firm's stores offer products and services for home decorating, maintenance, repair, and remodeling, with maintenance and repair accounting for two thirds of products sold. Lowe's targets retail do-it-yourself (around 75% of sales) and do-it-for-me customers as well as commercial and professional business clients (around 25% of sales). We estimate Lowe's captures a high-single-digit share of the domestic home improvement market, based on U.S. Census data and management's market size estimates.

Share on Social Networks: